Elizabeth A. Garofalo
CIK 1826361 · View on SEC EDGAR ↗
Insider
First SEC filing: June 3, 2021 · Latest: June 17, 2026
On this page
Insider at
Insider transactions
0 buys (P)
1 sells (S)
Net:
$-41,568
+ 56 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
56 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 2, 2025 | ACAD | S | 1,600 | $25.98 | $41,568 | 25,382 Direct | -5.93% | Disposed | 11.9% (price as of 2026-08-21) |
| March 5, 2025 | ACAD | S | 4,919 | $18.23 | $89,673 | 17,595 Direct | -21.85% | Disposed | 59.4% (price as of 2026-08-21) |
| March 8, 2024 | XENE | S | 2,092 | $45.69 | $95,583 | 0 Direct | -100.00% | Disposed | 31.7% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 17, 2026 | ALEC | Stock Option (right to buy) | Common Stock (9,450) | $0.00 | June 16, 2036 | 9,450 | Acquired |
| June 3, 2026 | XENE | Restricted Share Units | Common Shares (1,593) | $0.00 | — | 1,593 | Acquired |
| June 3, 2026 | XENE | Share Option (Right to Buy) | Common Shares (10,507) | $53.46 | June 2, 2036 | 10,507 | Acquired |
| June 1, 2026 | XENE | Restricted Share Units | Common Shares (2,645) | — | — | 2,645 | Disposed |
| May 29, 2026 | ACAD | Restricted Stock Units | Common Stock (9,311) | — | — | 9,311 | Acquired |
| May 29, 2026 | ACAD | Director Stock Options (Right to Buy) | Common Stock (16,004) | $21.66 | May 28, 2036 | 16,004 | Acquired |
| May 29, 2026 | ACAD | Restricted Stock Units | Common Stock (8,107) | — | — | 8,107 | Disposed |
| June 11, 2025 | ALEC | Stock Option (right to buy) | Common Stock (9,450) | $1.63 | June 10, 2035 | 9,450 | Acquired |
| June 5, 2025 | XENE | Restricted Share Units | Common Shares (2,645) | $0.00 | — | 2,645 | Acquired |
| June 5, 2025 | XENE | Share Option (Right to Buy) | Common Shares (17,012) | $30.73 | June 4, 2035 | 17,012 | Acquired |
| May 29, 2025 | ACAD | Restricted Stock Units | Common Stock (9,387) | — | — | 9,387 | Disposed |
| May 29, 2025 | ACAD | Director Stock Options (Right to Buy) | Common Stock (13,793) | $22.29 | May 28, 2035 | 13,793 | Acquired |
| May 29, 2025 | ACAD | Restricted Stock Units | Common Stock (8,107) | — | — | 8,107 | Acquired |
| June 5, 2024 | XENE | Stock Option (Right to Buy) | Common Shares (15,542) | $38.16 | June 4, 2034 | 15,542 | Acquired |
| May 29, 2024 | ACAD | Restricted Stock Units | Common Stock (6,652) | — | — | 6,652 | Disposed |
| May 29, 2024 | ACAD | Director Stock Options (Right to Buy) | Common Stock (15,959) | $14.62 | May 28, 2034 | 15,959 | Acquired |
| May 29, 2024 | ACAD | Restricted Stock Units | Common Stock (9,387) | — | — | 9,387 | Acquired |
| March 8, 2024 | XENE | Stock Option (Right to Buy) | Common Shares (20,000) | $18.56 | June 2, 2031 | 3,500 | Disposed |
| June 14, 2023 | ALEC | Stock Option (right to buy) | Common Stock (12,360) | $7.71 | June 14, 2033 | 12,360 | Acquired |
| June 2, 2023 | XENE | Stock Option (Right to Buy) | Common Shares (18,475) | $38.96 | June 1, 2033 | 18,475 | Acquired |
| June 1, 2023 | ACAD | Restricted Stock Units | Common Stock (6,652) | — | — | 6,652 | Acquired |
| June 1, 2023 | ACAD | Director Stock Options (Right to Buy) | Common Stock (11,045) | $23.90 | May 31, 2033 | 11,045 | Acquired |
| June 1, 2023 | ACAD | Restricted Stock Units | Common Stock (8,552) | — | — | 8,552 | Disposed |
| Sept. 29, 2022 | ACAD | Restricted Stock Units | Common Stock (1,919) | — | — | 1,919 | Disposed |
| June 28, 2022 | XENE | Stock Option (Right to Buy) | Common Shares (18,000) | $30.11 | June 27, 2032 | 18,000 | Acquired |
| June 16, 2022 | ALEC | Stock Option (right to buy) | Common Stock (18,918) | $8.07 | June 16, 2032 | 18,918 | Acquired |
| June 13, 2022 | XCUR | Employee Stock Option (right to buy) | Common Stock (50,000) | $0.13 | June 12, 2032 | 50,000 | Acquired |
| June 7, 2022 | ACAD | Restricted Stock Units | Common Stock (6,391) | — | — | 6,391 | Disposed |
| June 7, 2022 | ACAD | Restricted Stock Units | Common Stock (8,552) | — | — | 8,552 | Acquired |
| June 7, 2022 | ACAD | Director Stock Options (Right to Buy) | Common Stock (14,368) | $18.27 | June 6, 2032 | 14,368 | Acquired |
| Sept. 29, 2021 | ACAD | Restricted Stock Units | Common Stock (1,918) | — | — | 1,918 | Acquired |
| Sept. 23, 2021 | ALEC | Stock Option (right to buy) | Common Stock (33,235) | $24.26 | Sept. 23, 2031 | 33,235 | Acquired |
| June 22, 2021 | ACAD | Director Stock Options (Right to Buy) | Common Stock (11,637) | $24.88 | June 21, 2031 | 11,637 | Acquired |
| June 22, 2021 | ACAD | Restricted Stock Units | Common Stock (6,391) | — | — | 6,391 | Acquired |
| June 3, 2021 | XENE | Stock Option (Right to Buy) | Common Shares (20,000) | $18.56 | June 2, 2031 | 20,000 | Acquired |
| June 2, 2021 | XCUR | Stock Option (right to buy) | Common Stock (50,000) | $1.71 | June 1, 2031 | 50,000 | Acquired |
| March 5, 2021 | XCUR | Stock Option (right to buy) | Common Stock (100,000) | $2.06 | March 4, 2031 | 100,000 | Acquired |
| Sept. 29, 2020 | ACAD | Restricted Stock Units | Common Stock (3,837) | — | — | 3,837 | Acquired |
| Sept. 29, 2020 | ACAD | Stock Option (Right to Buy) | Common Stock (6,865) | $40.41 | Sept. 28, 2030 | 6,865 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.